The Long-term effects on antenatal glucocorticoids and preterm birth

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.advisor Anthony Rodgers en
dc.contributor.advisor Jane Harding en Dalziel, Stuart Ryan en 2009-01-27T21:08:27Z en 2009-01-27T21:08:27Z en 2005 en
dc.identifier.citation Thesis (PhD-Pediatrics)--University of Auckland, 2005. en
dc.identifier.uri en
dc.description.abstract Antenatal glucocorticoids are widely used in perinatal medicine, and are one of the key treatments responsible for improving survival of preterm infants since the 1960s. A systematic review reported in this thesis concludes that antenatal glucocorticoids reduce the risk of neonatal death, respiratory distress syndrome (RDS), intraventricular haemorrhage, necrotising enterocolitis, infectious morbidity and need for respiratory support. Several areas of uncertainty have been clarified, including the effectiveness of treatment in the current era of neonatal practice, and in women with hypertension syndromes and premature rupture of membranes. However there is a paucity of data on long-term outcomes after exposure to antenatal glucocorticoids. This is particularly important given recent proposals that fetal exposure to excess glucocorticoids may be a core mechanism explaining the epidemiological evidence that those born small are at increased risk of later adult disease. Furthermore, the relative contributions of fetal growth and prematurity to small size at birth, and hence later disease risk, has not been well elucidated. This thesis reports the follow-up of 534 thirty year olds whose mothers participated in the first, and largest, randomised trial of antenatal betamethasone for prevention of neonatal RDS. Two-thirds of participants were born preterm. Follow-up assessments included cardiovascular risk factors, spirometry, psychological assessment and bone densitometry. Exposure to antenatal betamethasone did not affect mortality, body size, blood pressure, lung function, fasting plasma levels of lipids, cortisol or IgE, socio-economic status, psychological functioning, health related quality of life or bone mass. However betamethasone-exposed participants showed increased insulin resistance. This is the first experimental evidence in man to demonstrate long-term metabolic effects of fetal glucocorticoid exposure. However, as all other outcomes are reassuring, and treatment significantly reduces neonatal mortality and morbidity, obstetricians should continue to use a single course of glucocorticoids for the prevention of neonatal RDS. Adults who were born preterm had increased blood pressure, insulin resistance, reduced lung function and reduced adult height at age thirty. This is the largest reported follow-up of ex-preterm infants into adulthood. Although the associations are relatively small, their potential implications for the prevalence of later chronic obstructive pulmonary and cardiovascular disease are of concern. en
dc.format Scanned from print thesis en
dc.language.iso en en
dc.publisher ResearchSpace@Auckland en
dc.relation.ispartof PhD Thesis - University of Auckland en
dc.relation.isreferencedby UoA1666322 en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. en
dc.rights.uri en
dc.title The Long-term effects on antenatal glucocorticoids and preterm birth en
dc.type Thesis en Pediatrics en The University of Auckland en Doctoral en PhD en
dc.subject.marsden Fields of Research::320000 Medical and Health Sciences en
dc.rights.holder Copyright: The author en
pubs.local.anzsrc 11 - Medical and Health Sciences en
dc.rights.accessrights en Faculty of Medical & Hlth Sci en

Full text options

This item appears in the following Collection(s)

Show simple item record


Search ResearchSpace

Advanced Search